Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

NCT06073574 is registered in ClinicalTrials.gov with Ionis Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06073574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06073574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study
Lead sponsor
Ionis Pharmaceuticals, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2021
Completion date
March 13, 2026
Enrollment
160 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin-mediated amyloid cardiomyopathy (attr-cm)